Autologous Volar Fibroblast Injection Into the Stump Site of Amputees

Status Recruiting

Clinical Trial Summary

Clinical Trial Description

This study is a clinical trial testing the safety and efficacy of volar fibroblast (skin cells from the palm or sole) injections for thickening the epidermal (skin) layer at the stump site in people with below the knee amputations. The study will enroll adults seen at Johns Hopkins. The investigators have demonstrated that injection of fibroblasts (from the palm or sole) is safe in healthy adults and potentially enhances palm or sole features in skin cells in areas other than the palm and sole. In a prior study, healthy adults injected with fibroblasts (from the palm or sole) experienced more firm skin at the injection site. The objective of this study is to determine if fibroblast (from palm or sole) injections are safe and effective at increasing epidermal thickness and skin firmness at the stump site in below the knee amputees. Outcomes are assessed via questionnaires, non-invasive imaging devices, and non-invasive skin firmness measuring devices. Injections will be targeted to the entire stump (unless determined otherwise by the PI and participant), including pressure intolerant areas of the skin that come into contact with the prosthetic socket, a region that is prone to skin irritation and breakdown, We will evaluate the most effective approach to administering this intervention via injections to the entire stump and the safety and effectiveness of whole stump injections and their effects on prosthesis use, skin breakdown, quality of life, and activity level. The investigators hope that information from this study will help with problems like skin breakdown in patients with amputations and prosthetics. The skin at the stump was not meant to withstand the pressure and friction of prosthetics and this study is the first step in trying to convert stump skin to palm/sole-like skin. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03947450
Study type	Interventional
Source	Johns Hopkins University
Contact	Ruizhi Wang, MPhil
Phone	410-502-7546
Email	rwang53@jhmi.edu
Status	Recruiting
Phase	Phase 2
Start date	September 5, 2019
Completion date	April 1, 2028

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04924036` - Qbrexza Cloths for Hyperhidrosis of Amputation Sites	Phase 2
Recruiting	`NCT04839497` - Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of Amputees.	Phase 2
Recruiting	`NCT04212299` - Transfemoral Socket Design and Muscle Function	N/A
Completed	`NCT03733054` - Understanding Prosthetic Needs and Outcomes in Women Veterans With Amputation
Completed	`NCT03651830` - A Test-Drive Strategy for the Prescription of Prosthetic Feet for People With Leg Amputations	N/A
Recruiting	`NCT04725006` - Sensory Responses to Dorsal Root Stimulation	N/A
Not yet recruiting	`NCT06007885` - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.	N/A
Not yet recruiting	`NCT04936789` - Clinical Feasibility of the IMES Transradial Prosthesis	N/A
Completed	`NCT01155024` - Clinical Evaluation of Direct Manufactured Prosthetic Sockets	Phase 2
Completed	`NCT00663663` - Telephone Intervention for Pain Study (TIPS)	N/A
Terminated	`NCT00778856` - Hand Transplantation for the Reconstruction of Below the Elbow Amputations	N/A
Recruiting	`NCT00388752` - Acupuncture for the Treatment of Phantom Limb and Residual Limb Pain After Amputation	Phase 1
Active, not recruiting	`NCT03374319` - Somatotopic Configuration of Distal Residual Limb Tissues in Lower Extremity Amputations	N/A
Completed	`NCT05542901` - Comparison of Joint Position Sense in Diabetic and Traumatic Transtibial Amputees	N/A
Completed	`NCT05161364` - Kinetic Analysis Due to Foot Dysfunction
Recruiting	`NCT06194838` - Clinical Outcomes With Non-Powered vs. Powered Prosthetic Knees by K2-level Amputees	N/A
Completed	`NCT03570788` - HRQoL Among Patients Amputated Due to Peripheral Arterial Disease
Completed	`NCT05778799` - Physical Activity and Sports for People With Special Needs
Recruiting	`NCT04804150` - Daily Socket Comfort in Transtibial Amputee With an Active Vacuum Suspension System	N/A
Terminated	`NCT03259386` - Movement and Sensation for Advanced Prosthetic Hands

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.